comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders
Yuqi Shen(MRC Weatherall Institute of Molecular Medicine), Abdullah O. Khan(MRC Weatherall Institute of Molecular Medicine)
Cited by 3
Related Papers
Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies
|bioRxiv (Cold Spring Harbor Laboratory)|2022|6
ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression
|Nature Communications|2026|0